Owners, management and financials
CVR: 43279092
DKK 7,117,285
Gross profit
Net result: DKK 413,813
INTEGRA Biosciences Holding AG (100%)
CVR · view owners
Kirsten Thuesen, Sven Karl Linder
1 more in management
CVR · view management
Active
Founded 18 May 2022
CVR · view overview
6 employees
Annual report 2025 · average
Director role ended: Thomas Schrofer
CVR · 20/02/2026
View the full event history
INTEGRA Biosciences Nordic ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2022. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The management consists of Kirsten Thuesen, Sven Karl Linder and Torbjørn Gripp. The company is owned by INTEGRA Biosciences Holding AG. According to the 2025 annual report, the company had an average of 6 employees. In 2025, the company reported a gross profit of DKK 7,117,285 and a net result of DKK 413,813 compared with DKK -1,699,859 the year before. Equity in the 2025 report amounted to DKK -3,235,625.
Source: annual report 2025, Danish Business Authority
The financial health of INTEGRA Biosciences Nordic ApS shows a concerning trajectory, with a consistent decline in equity and fluctuating gross profits over the past three years. Gross profit increased from 2,905,351 DKK in 2023 to 7,117,285 DKK in 2025, indicating potential growth in operational efficiency; however, the company reported a profit of only 413,813 DKK in 2025 after two years of losses, highlighting ongoing profitability challenges. The negative equity position, which worsened from -1,949,578 DKK in 2023 to -3,235,625 DKK in 2025, raises concerns about financial stability and leverage. As a relatively new entrant in the machinery and equipment wholesale industry, the company must address these financial issues to strengthen its market position and ensure long-term viability.
AI-generated summary · Generated 14/08/2026
Selskabets formål er at handle med varer, sælge services og dermed forbundet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 7.1 mio. | 414 t. | 10.4 mio. | -3.2 mio. | 6 | |
| 202401/01/2024 – 31/12/2024 | 4.1 mio. | -1.7 mio. | 11.5 mio. | -3.6 mio. | 6 | |
| 202301/01/2023 – 31/12/2023 | 2.9 mio. | -956 t. | 8.6 mio. | -1.9 mio. | 4 |
Compared to 1.742 companies in Engroshandel med andre maskiner og andet udstyr
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
1 public tender won
Sources: TED (the EU tender database) and udbud.dk
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of INTEGRA Biosciences Nordic ApS is 43279092.
INTEGRA Biosciences Nordic ApS is owned by INTEGRA Biosciences Holding AG.
The management of INTEGRA Biosciences Nordic ApS consists of Kirsten Thuesen, Sven Karl Linder and Torbjørn Gripp.
In 2025, INTEGRA Biosciences Nordic ApS reported a gross profit of DKK 7,117,285.
INTEGRA Biosciences Nordic ApS had an average of 6 employees in the 2025 financial year according to the annual report.
INTEGRA Biosciences Nordic ApS was founded on 18 May 2022.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 31735373, new email: [email protected] (February 27, 2026).
INTEGRA Biosciences Nordic ApS has published its annual report for 2025. Gross profit came to DKK 7,117,285, and the net result was DKK 413,813.
As of February 20, 2026, Sven Karl Linder is registered as director of INTEGRA Biosciences Nordic ApS.
As of February 20, 2026, Thomas Schrofer has stepped down as director of INTEGRA Biosciences Nordic ApS.
INTEGRA Biosciences Nordic ApS has won the tender "Udbud af Pipetter med tilhørende originale pipettespidser til danske universiteter (KU, AU, AAU, DTU, SDU)" issued by Danmarks Tekniske Universitet - DTU worth 60,192,963 DKK.
INTEGRA Biosciences Nordic ApS has published its annual report for 2024. Gross profit came to DKK 4,115,411, and the net result was DKK -1,699,859.
As of January 16, 2025, BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of INTEGRA Biosciences Nordic ApS.
INTEGRA Biosciences Nordic ApS has published its annual report for 2023. Gross profit came to DKK 2,905,351, and the net result was DKK -956,194.
INTEGRA Biosciences Nordic ApS has published its interim report for the period May 18, 2022 – December 31, 2022.
As of May 18, 2022, Kirsten Thuesen is registered as director of INTEGRA Biosciences Nordic ApS.
As of May 18, 2022, Torbjørn Gripp is registered as director of INTEGRA Biosciences Nordic ApS.
As of May 18, 2022, Thomas Schrofer is registered as director of INTEGRA Biosciences Nordic ApS.
As of May 18, 2022, is registered as an owner of INTEGRA Biosciences Nordic ApS with an ownership share of 100%.
INTEGRA Biosciences Nordic ApS was founded on May 18, 2022.
Companies in the same industry and area
CVR 11744281
CVR 30766016
CVR 63700010
CVR 25132408
CVR 27480357
